A new President for SGH Medical Pharma
Olivier Derouard, previously Sales and Marketing Director at SGH Medical Pharma, has been appointed President of the group. He succeeds Jérôme Empereur, who had held this position since 2013.
This governance transition, prepared over the past several months, ensures the continuation of the Group’s strategic direction. Jérôme Empereur will remain engaged with the company as Operating Partner, focusing on strategic initiatives designed to support the execution of SGH Medical Pharma’s ambitious roadmap.
Strengthening our position as a leading European plastics manufacturer
The Group aims to strengthen its position as a leading European plastics manufacturer specializing in drug delivery, respiratory care, and diagnostics by leveraging three strategic pillars:
- A world-class industrial platform: our multi-certified facilities including our GMP-certified pharmaceutical site in Saint-Marcellin ensure operational excellence and outstanding responsiveness.
- Growth momentum in France and internationally: with growth of more than 50% in recent years, we are accelerating our development. Already established in Tunisia, we are strengthening our presence in the United States and Southeast Asia.
- Innovation at the core of our value proposition: our R&D teams design tailor-made solutions as well as innovative proprietary technologies that highlight our expertise.
Olivier Derouard - CEO of SGH Medical Pharma
“SGH Medical Pharma is a wonderful French mid-sized company. With its promising prospects, our motivated teams are ready to take it even further. I am honored by the trust our investors have placed in me and delighted to see Jérôme continuing the adventure alongside us. Our roadmap is exciting and challenging! At the end of the month, at CPHI in Frankfurt, we will be presenting a new range of accessories for dosing pipettes that truly reflects our expertise, innovation, and industrialization capabilities.”